EYPT
Eyepoint Pharmaceuticals Inc
3.30$
+0.6%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -1,153.7% | -870.6% | -1,484.3% | -901.9% | -1,195.9% | -610.3% | -42.3% | 42.9% | 199.4% | -89.9% | -420.0% | -251.8% | 38.8% | 38.8% | -1,007.2% | -271.8% | -374.1% | -278.4% | -41.9% | -135.6% | -157.0% | 4.1% | -291.7% | -765.4% | |
| 80.0% | 38.6% | 197.3% | 119.9% | 617.0% | 250.8% | 3.3% | 14.4% | 67.6% | 63.2% | 46.4% | 26.4% | 3.3% | 3.4% | 50.3% | 10.8% | 19.6% | 12.8% | 7.7% | 7.5% | 5.9% | 1.0% | 3.6% | 7.4% | |
| – | – | – | -47.8% | 43.3% | 21.7% | -0.1% | 6.5% | 41.3% | 40.0% | 61.5% | 40.6% | 7.4% | 8.1% | 151.6% | 32.6% | 67.7% | 22.4% | 16.1% | 20.2% | 34.2% | 26.2% | 84.9% | 88.8% | |
| – | – | – | – | – | – | – | – | – | 455.4% | 61.5% | 38.4% | 7.4% | 8.1% | 151.6% | 384.4% | 839.0% | 46.3% | 21.6% | 18.0% | 92.7% | – | – | – | |
| 97.7% | -54.3% | -53.9% | 240.2% | 65.2% | 387.1% | -85.9% | -17.4% | -80.9% | 34.3% | 32.3% | 11.2% | 3.8% | 7.8% | 19.6% | 3.3% | -16.1% | -61.6% | 58.5% | -4.7% | -7.3% | 128.0% | -64.2% | -107.7% | |
| 13.4% | 58.7% | 411.4% | 250.0% | 64.7% | 2.4% | 2.2% | 0.8% | 0.3% | 3.8% | 18.9% | 2.0% | 0.9% | 0.6% | 7.0% | 1.9% | 1.8% | 1.0% | 1.1% | 0.4% | 5.2% | 7.6% | 9.4% | 10.5% | |
| -13.2% | -58.7% | – | -398.6% | -231.4% | 51.0% | -2.1% | -9.0% | -191.3% | 17.2% | 296.7% | 1.9% | 0.2% | -16.8% | 838.1% | -224.0% | -288.4% | -1.0% | -1.1% | -89.7% | -41.7% | -7.2% | -506.9% | 218.6% | |
| – | – | – | – | – | – | – | – | – | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | -64.4% | – | – | – | 3.2% | 217.9% | 28.4% | 0.9% | 64.0% | 524.9% | 557.3% | -3.3% | -0.6% | -0.3% | -0.4% | -0.7% | -0.4% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | 75.3% | 75.3% | 1,234.6% | 247.4% | 341.5% | 127.4% | -42.5% | -0.4% | -1.6% | -88.0% | -0.2% | -0.3% | |
| 215.9% | 442.7% | 439.0% | 2,117.7% | 1,213.0% | 528.9% | 151.2% | 3.5% | 202.6% | 285.3% | 217.9% | 548.3% | 71.7% | 64.0% | 524.9% | 112.8% | 498.7% | 166.3% | 108.9% | 587.2% | -1.7% | 406.5% | 379.0% | 553.5% | |
| -980.6% | 3,358.4% | -2,226.7% | -1,353.0% | 106.3% | -300.1% | 106.4% | -37.8% | 173.5% | -73.8% | -386.7% | 65.5% | 31.8% | 14.3% | -235.1% | 21.0% | 373.6% | -113.2% | 65.9% | 361.9% | -200.4% | 403.4% | -419.6% | 6.7% | |
| -1,167.1% | -929.3% | -1,895.7% | -1,151.9% | -968.8% | -612.7% | -44.5% | -37.4% | 199.1% | -93.7% | -438.9% | -253.8% | -41.1% | 38.2% | -1,014.1% | -273.7% | -375.9% | -279.5% | -43.0% | -136.0% | -162.2% | -3.5% | -301.1% | -775.8% |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.